Infections à rubivirus : Questions médicales fréquentes
Nom anglais: Rubivirus Infections
Descriptor UI:D018355
Tree Number:C01.925.782.930.700
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à rubivirus : Questions médicales les plus fréquentes",
"headline": "Infections à rubivirus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à rubivirus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à rubivirus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à Togaviridae",
"url": "https://questionsmedicales.fr/mesh/D014036",
"about": {
"@type": "MedicalCondition",
"name": "Infections à Togaviridae",
"code": {
"@type": "MedicalCode",
"code": "D014036",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.930"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rubéole",
"alternateName": "Rubella",
"url": "https://questionsmedicales.fr/mesh/D012409",
"about": {
"@type": "MedicalCondition",
"name": "Rubéole",
"code": {
"@type": "MedicalCode",
"code": "D012409",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.930.700.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Infections à rubivirus",
"alternateName": "Rubivirus Infections",
"code": {
"@type": "MedicalCode",
"code": "D018355",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pratyush Kumar Das",
"url": "https://questionsmedicales.fr/author/Pratyush%20Kumar%20Das",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA."
}
},
{
"@type": "Person",
"name": "Margaret Kielian",
"url": "https://questionsmedicales.fr/author/Margaret%20Kielian",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA margaret.kielian@einsteinmed.org."
}
},
{
"@type": "Person",
"name": "O A Shamsutdinova",
"url": "https://questionsmedicales.fr/author/O%20A%20Shamsutdinova",
"affiliation": {
"@type": "Organization",
"name": "FSBRI «Research Institute of Medical Primatology» of the Ministry of Education and Science of Russia."
}
},
{
"@type": "Person",
"name": "D D Karal-Ogly",
"url": "https://questionsmedicales.fr/author/D%20D%20Karal-Ogly",
"affiliation": {
"@type": "Organization",
"name": "FSBRI «Research Institute of Medical Primatology» of the Ministry of Education and Science of Russia."
}
},
{
"@type": "Person",
"name": "Gaojian Li",
"url": "https://questionsmedicales.fr/author/Gaojian%20Li",
"affiliation": {
"@type": "Organization",
"name": "National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Intestinal parasitic infections and risk factors for infection in Kenyan children with and without HIV infection.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36464230",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parint.2022.102717"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anti-infective management of infected skin ulcers.",
"datePublished": "2024-06-01",
"url": "https://questionsmedicales.fr/article/38827836",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.53854/liim-3202-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype.",
"datePublished": "2024-01-09",
"url": "https://questionsmedicales.fr/article/38195666",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-44330-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Definition of the Term \"Orthogeriatric Infection\" for Periprosthetic Joint Infections.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35794870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/21514593221111649"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disseminated Gonococcal Infection Due to a Mediport Catheter Infection.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/38046706",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.48180"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections à Togaviridae",
"item": "https://questionsmedicales.fr/mesh/D014036"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à rubivirus",
"item": "https://questionsmedicales.fr/mesh/D018355"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à rubivirus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à rubivirus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à rubivirus",
"description": "Comment diagnostique-t-on une infection à rubivirus ?\nQuels tests sont utilisés pour confirmer une rubéole ?\nPeut-on diagnostiquer la rubéole par PCR ?\nQuels symptômes indiquent une rubéole ?\nQuand faire un test de rubéole pendant la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D018355?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à rubivirus",
"description": "Quels sont les symptômes courants de la rubéole ?\nLa rubéole cause-t-elle des complications ?\nLes symptômes de la rubéole sont-ils similaires à ceux d'autres maladies ?\nLa rubéole provoque-t-elle des symptômes chez tous les patients ?\nCombien de temps durent les symptômes de la rubéole ?",
"url": "https://questionsmedicales.fr/mesh/D018355?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à rubivirus",
"description": "Comment prévenir la rubéole ?\nQui doit être vacciné contre la rubéole ?\nLa rubéole peut-elle être évitée par l'immunité collective ?\nLes femmes enceintes doivent-elles se faire vacciner ?\nQuels sont les effets secondaires du vaccin contre la rubéole ?",
"url": "https://questionsmedicales.fr/mesh/D018355?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à rubivirus",
"description": "Quel est le traitement principal pour la rubéole ?\nLes antibiotiques sont-ils efficaces contre la rubéole ?\nComment soulager les symptômes de la rubéole ?\nLa vaccination peut-elle traiter la rubéole ?\nQuand consulter un médecin pour la rubéole ?",
"url": "https://questionsmedicales.fr/mesh/D018355?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à rubivirus",
"description": "Quelles sont les complications possibles de la rubéole ?\nLa rubéole peut-elle affecter le fœtus ?\nQuels sont les risques d'encéphalite liée à la rubéole ?\nLa rubéole peut-elle entraîner des problèmes auditifs ?\nQuels sont les effets à long terme de la rubéole ?",
"url": "https://questionsmedicales.fr/mesh/D018355?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à rubivirus",
"description": "Qui est le plus à risque de rubéole ?\nLes voyages à l'étranger augmentent-ils le risque de rubéole ?\nLes épidémies de rubéole sont-elles fréquentes ?\nLes adolescents sont-ils à risque de rubéole ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D018355?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à rubivirus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques pour détecter les anticorps anti-rubéole."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer une rubéole ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests IgM et IgG dans le sang sont utilisés pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer la rubéole par PCR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut détecter le virus dans les échantillons de sang ou de liquide amniotique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une rubéole ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruption cutanée, fièvre, et ganglions lymphatiques enflés."
}
},
{
"@type": "Question",
"name": "Quand faire un test de rubéole pendant la grossesse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de tester les femmes enceintes en début de grossesse."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la rubéole ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, éruption cutanée, et douleurs articulaires."
}
},
{
"@type": "Question",
"name": "La rubéole cause-t-elle des complications ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications comme l'encéphalite ou des malformations congénitales."
}
},
{
"@type": "Question",
"name": "Les symptômes de la rubéole sont-ils similaires à ceux d'autres maladies ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux de la rougeole ou de la varicelle."
}
},
{
"@type": "Question",
"name": "La rubéole provoque-t-elle des symptômes chez tous les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent être asymptomatiques, surtout les enfants."
}
},
{
"@type": "Question",
"name": "Combien de temps durent les symptômes de la rubéole ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes durent généralement de 3 à 7 jours."
}
},
{
"@type": "Question",
"name": "Comment prévenir la rubéole ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est le moyen le plus efficace de prévenir la rubéole."
}
},
{
"@type": "Question",
"name": "Qui doit être vacciné contre la rubéole ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants et les femmes en âge de procréer doivent être vaccinés."
}
},
{
"@type": "Question",
"name": "La rubéole peut-elle être évitée par l'immunité collective ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une couverture vaccinale élevée aide à protéger ceux qui ne peuvent pas être vaccinés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se faire vacciner ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la vaccination est recommandée avant la grossesse, pas pendant."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires du vaccin contre la rubéole ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure une légère fièvre ou une éruption cutanée temporaire."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour la rubéole ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et les antipyrétiques sont recommandés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la rubéole ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car la rubéole est virale."
}
},
{
"@type": "Question",
"name": "Comment soulager les symptômes de la rubéole ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments contre la douleur et la fièvre peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "La vaccination peut-elle traiter la rubéole ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la vaccination prévient l'infection, mais ne traite pas une infection existante."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour la rubéole ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si vous présentez des symptômes ou si vous êtes enceinte."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la rubéole ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'encéphalite, la thrombocytopénie et des malformations congénitales."
}
},
{
"@type": "Question",
"name": "La rubéole peut-elle affecter le fœtus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'infection pendant la grossesse peut causer des malformations congénitales graves."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'encéphalite liée à la rubéole ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'encéphalite est rare mais peut survenir, surtout chez les adultes infectés."
}
},
{
"@type": "Question",
"name": "La rubéole peut-elle entraîner des problèmes auditifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des surdités congénitales chez les bébés infectés in utero."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme de la rubéole ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des problèmes de développement et des troubles auditifs."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de rubéole ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes non vaccinées et les femmes enceintes sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque de rubéole ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où la rubéole est endémique augmente le risque."
}
},
{
"@type": "Question",
"name": "Les épidémies de rubéole sont-elles fréquentes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les épidémies peuvent survenir dans les populations non vaccinées."
}
},
{
"@type": "Question",
"name": "Les adolescents sont-ils à risque de rubéole ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les adolescents non vaccinés sont également à risque d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus vulnérables aux infections, y compris la rubéole."
}
}
]
}
]
}
It has been reported that HIV infection is not a risk factor for Entamoeba species infection but is for Giardia intestinalis assemblage B in children living in Western Kenya. This study aimed to inves...
Dengue viruses (DENV1-4) are the most prevalent arboviruses in humans and a major public health concern. Understanding immune mechanisms that modulate DENV infection outcome is critical for vaccine de...
In the background of the aging population, an increase of geriatric patients with specific age-related co-morbidities has already been seen over the years for proximal femur fractures in orthopaedic s...
In this single-center retrospective study, patients treated between 2007 and 2020 for PJI were included (n = 255). Patients were defined as geriatric according to the consensus definition criteria of ...
Applying the criteria defined 184 of the 255 (72.2%) PJI patients as geriatric infection patients. Regarding geriatric comorbidity, incontinence was most prevalent (38.1%), followed by immobility (25....
We propose to use the term orthogeriatric infection patients in those cases in order to focus treatment not only on the orthopaedic infections but also on the important geriatric aspects....
The inclusion of geriatric physicians into the multidisciplinary team approach for PJI patients might be beneficial....
The protection conferred by natural immunity, vaccination, and both against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the BA.1 or BA.2 sublineages of the ...
We conducted a national, matched, test-negative, case-control study in Qatar from December 23, 2021, through February 21, 2022, to evaluate the effectiveness of vaccination with BNT162b2 (Pfizer-BioNT...
The effectiveness of previous infection alone against symptomatic BA.2 infection was 46.1% (95% confidence interval [CI], 39.5 to 51.9). The effectiveness of vaccination with two doses of BNT162b2 and...
No discernable differences in protection against symptomatic BA.1 and BA.2 infection were seen with previous infection, vaccination, and hybrid immunity. Vaccination enhanced protection among persons ...
Microsporidia and Cryptosporidium are obligate intracellular protozoa. These medically important species are recognized as opportunistic organisms in intestinal complications in human immunodeficiency...
The current cross-sectional study was designed and conducted from August 2016 to August 2017 to determine intestinal Cryptosporidium and microsporidia spp. in HIV-infected individuals from the Behavio...
Of 100 HIV-infected persons, 21.0% (95% confidence interval [CI] 13.0 to 30.0) and 18.0% (95% CI 11.0 to 26.0) were identified as Cryptosporidium and microsporidia, respectively, by the microscopic me...
As far as we know, this study is the first to estimate the prevalence of infection with Cryptosporidium and microsporidia among HIV-infected persons in northwest of Iran. The prevalence of intestinal ...
We formulate a general age-of-infection epidemic model with two pathways: the symptomatic infections and the asymptomatic infections. We then calculate the basic reproduction number [Formula: see text...
Macrophages contribute to Ebola virus disease through their susceptibility to direct infection, their multi-faceted response to ebolaviruses, and their association with pathological findings in tissue...